Organization | Province of Barcelona, Spain

Province of Barcelona, Spain Report issue

Government Phase 3

Organization Overview

First Clinical Trial

2012

NCT01631266

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2012

Timeline

NOW

Now

Alternative names

HOSPITAL CLINIC I PROVINCIAL DE BARCELONA | Public Health Agency of Barcelona

Active Ingredients

Drugs in Phase 3 Trials (2)

inactivated influenza vaccine (1 trial)

Tuberculin, Purified Protein Derivative (Tubersol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Influenza, Human (Phase 3)

Tuberculosis (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 2